newsMSD investment confirms thriving biopharmaceutical hub11 June 2017 | By Niamh Marriott (European Pharmaceutical Review)MSD to invest €280 million in Ireland over the next three years bolsters the country’s status as a thriving hub for the biopharmaceutical sector...